Form 4 for GLSI Greenwich LifeSciences, Inc.
Accepted 2022-01-19 00:00:00 ET · period of report 2022-01-18 · accession 0001493152-22-001542 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-19 | 2022-01-18 | GLSI | Thompson Jaye | VP Clinical Reg. Affairs | P - Purchase | $18.87 | +500 | 254.5K | +0.2% | +$9,435 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-18 | P | A | 500 | $18.87 | 254,495 | D | — | — |